Who owns Brink Therapeutics?

Brink Therapeutics is currently owned by Breega, through Breega Seed fund, since 2025.

When did Breega acquire Brink Therapeutics?

Breega acquired Brink Therapeutics in 2025 (active for 1 year).

Healthcare·

France·Active·1yr hold

Brink Therapeutics is a healthcare company, headquartered in France.

Entry

2025

Hold

1yr

Status

Active

Est. EV

–

Investor

HQFrance

SectorHealthcare

StatusActive

Gene editing recombinases. 3.5M Seed April 2025.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Full fund context: vintage, strategy, region

5 portfolio peers in Breega Seed fund

6 comparable healthcare deals from other GPs

Already a member? Sign in

Data refreshed weekly · Sourced from public filings